Table 1.
Characteristic | Young Fibroblasts | Senescent Fibroblasts | ||
---|---|---|---|---|
THC | CBD | H2O2 + THC | H2O2 + CBD | |
Shape and size of the cell | Elongated, small | Elongated, small | Enlarged, flattened | Enlarged, flattened |
Nuclear Area | ↓ | ↔ | ↔ | ↔ |
Nuclear Perimeter | ↓ | ↔ | ↔ | ↔ |
Nuclear Eccentricity | ↑ | ↔ | ↔ | ↔ |
Nuclear circularity (roundness) | ↓ | ↔ | ↔ | ↔ |
β-Gal level | ↑ | ↔ | ↓ | ↓ |
BID | ↔ | ↔↑ | ↔↓ | ↓ |
CB1 | ↔↑ | ↔↑ | ↔ | ↔ |
CB2 | ↔↑ | ↔↑ | ↔ | ↔↑ |
CDK2 | ↔↑ | ↔↑ | ↔↓ | ↔↓ |
c-Jun | ↔↓ | ↔ | ↔ | ↔↓ |
Collagen (type I) | ↔ | ↔↓ | ↔↑ | ↔↑ |
Collagen (type III) | ↔ | ↔ | ↔ | ↔ |
Cyclin D1 | ↔ | ↔↓ | ↓ | ↓ |
EGFR | ↓ | ↔ | ↑ | ↔ |
Elastin | ↔ | ↔ | ↔↓ | ↓ |
GDF11 | ↔↑ | ↑ | ↔ | ↔↑ |
Hyaluronan synthase | ↑ | ↑ | ↔↑ | ↔↑ |
MMP 1 | ↑ | ↔ | ↓ | ↔↓ |
MMP 2 | ↔ | ↔ | ↔↑ | ↔↑ |
MKI67 | ↑ | ↑ | ↔ | ↑ |
NF-κB | ↔↑ | ↔↑ | ↔↓ | ↔↑ |
P16 | ↔ | ↔↑ | ↑ | ↔↑ |
P21 | ↔↓ | ↔↓ | ↔ | ↑ |
P53 | ↔↑ | ↔↑ | ↔ | ↔↓ |
PCNA | ↔ | ↔ | ↔ | ↔ |
SIRT 1 | ↔↑ | ↔↑ | ↔ | ↔ |
SIRT 3, 4 | ↔↑ | ↔↑ | ↔↓ | ↔ |
SIRT 6 | ↑ | ↔↑ | ↔↓ | ↔ |
TIMP 1 | ↔↑ | ↔↑ | ↔↓ | ↔↓ |
Vinculin | ↔↓ | ↓ | ↔ | ↔ |
Cell viability | ↑ | ↔ | ↑ | ↑ |
Wound healing | ↑ | ↑ | ↑ | ↑ |
Results compared to vehicle control, DMSO in healthy fibroblasts group, and H2O2 + DMSO. In senescent fibroblast group. ↓, Decreased/low; ↑, Increased/high; ↔, no change detected; ↔↓, tendency to decrease; ↔↑, tendency to increase.